PremiumRatingsHold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans Third Harmonic Bio downgraded to Hold from Buy at Stifel PremiumCompany AnnouncementsThird Harmonic Bio Advances THB335 for Inflammatory Diseases Biotech Alert: Searches spiking for these stocks today Third Harmonic Bio, Inc.: Hold Rating Amid Strategic Uncertainty and Safety Concerns PremiumThe FlyMorning Movers: Lattice Semiconductor, SelectQuote jump after earnings reports Third Harmonic Bio, Inc. Announces Restructuring Plan Third Harmonic Bio announces Phase 1 clinical results for THB335